Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Bullboard - Stock Discussion Forum Lipella Pharmaceuticals Inc LIPO

Healthcare Biotechnology

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Its lead product candidates include LP-10, LP-310 and LP-410. LP-10 is the development name of its reformulation of tacrolimus specifically optimized for topical... see more

Add To Watchlist

Bullboard (NDAQ:LIPO)

View:

Post by PressReleaseon Aug 27, 2024 8:00am

New Press Release - Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York

Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway PITTSBURGH, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global...read article.

Post by PressReleaseon Aug 22, 2024 5:00am

New Press Release - Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLPPatient registry and OLP study information is now available PITTSBURGH, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Lipella...read article.

Promino Nutritional Sciences Inc. Provides Shareholder Progress Report

posted Dec 14, 2024 9:00am by Promino Nutritional Sciences Inc.

Promino Nutritional Science's rejuvenate muscle activator, delivers the equivalent of 40 grams of whey protein isolate for just 3.6 grams of the company’s product. That was just one of the highlights in the company’s update to investors covering a transformational period for the company as new management resurrects sales with an eye on the RTD market in 2025 ...read more

Post by PressReleaseon Aug 21, 2024 5:00am

New Press Release - Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancerNovel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto...read article.

Post by PressReleaseon Aug 12, 2024 5:00am

New Press Release - Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Top Line Data Expected Year-End 2024 PITTSBURGH, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the...read article.

Post by MikeTesteron Aug 03, 2024 1:53am

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO): Reformulating Ge

https://beyondspx.com/2024/08/02/lipella-pharmaceuticals-inc-nasdaqlipo-reformulating-generic-drugs-for-new-applications/

22

Post by PressReleaseon Aug 01, 2024 4:05pm

New Press Release - Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

PITTSBURGH, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously announced registered direct...read article.

Post by PressReleaseon Aug 01, 2024 8:00am

New Press Release - Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

PITTSBURGH, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement for the...read article.

Comment by Iseneschalon Jul 31, 2024 12:39pm

RE:LIPO.....3 mins til opening bell

Live and learn Chasers!!!!!!!!!!!!!!!!!!

15

Discussion

Post by Iseneschalon Jul 29, 2024 10:25am

LIPO....N.L.O.D...now at $0.9255

How do u like me so far ?????

27

Post by Iseneschalon Jul 29, 2024 10:18am

LIPO....sub $1 now

say goodnight sweet sharlet

29

Post by Iseneschalon Jul 29, 2024 10:13am

LIPO...Halt #2.....locked at $1

should resume in 2 mins I will say it now..... You've all been had.....AGAIN !!!!!

21

Post by Iseneschalon Jul 29, 2024 9:51am

LIPO....N.L.O.D

$1.08

29

Post by Iseneschalon Jul 29, 2024 9:39am

LIPO...this better get up past $1.26 in a hurry

or its toast

30

Post by Iseneschalon Jul 29, 2024 9:36am

LIPO....halted on the way down

It will return in 1 min...$1.23

29

Post by Iseneschalon Jul 29, 2024 9:28am

LIPO.....3 mins til opening bell

now trading over $1.40 Calling all the Chasers ....buy high sell low

29

Discussion

The Market Update

{{currentVideo.title}} {{currentVideo.relativeTime}}

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}

{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}

{{currentVideo.headline}}

{{currentVideo.link1Text}}

{{currentVideo.link2Text}}

< Previous

{{moreVideoText}}

Next >

Dealroom for high-potential pre-IPO opportunities

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.